This HTML5 document contains 56 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
schemahttp://schema.org/
rdfshttp://www.w3.org/2000/01/rdf-schema#
skoshttp://www.w3.org/2004/02/skos/core#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n10http://dx.doi.org/10.1111/
n8http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q58434729
rdf:type
wikibase:Item
schema:description
wetenschappelijk artikel artículu científicu espublizáu n'agostu de 2018 наукова стаття, опублікована в серпні 2018 im August 2018 veröffentlichter wissenschaftlicher Artikel scientific article published on 14 August 2018
p:P577
wds:Q58434729-6A33F280-2F67-49BF-9C6E-BCF440549025
wdt:P577
2018-08-14T00:00:00Z
p:P407
wds:Q58434729-0E7F623C-6842-409E-85FA-289B5E687DDA
wdt:P407
wd:Q1860
p:P2093
wds:Q58434729-A2EAF080-B06E-4C04-A623-516F2F1ABD37 wds:Q58434729-BE50DC17-4358-4729-BF64-5DFCA24E4DA2 wds:Q58434729-A02A145E-9AEE-4A68-A965-ECBCEE6E3BA6 wds:Q58434729-6C170146-45BF-4F63-8CEB-086C4CB1ECBB wds:Q58434729-67BCC88A-9CBE-4F3E-95E6-F990EADAB70D wds:Q58434729-449F0257-AC8F-41AB-A17E-4EDC0BBC65C2 wds:Q58434729-34E4D854-A8D7-41E2-BD65-C3395543397B
wdt:P2093
SUPREME Study Group L Bianchi M Bartezaghi G Castellino G Malara L Carraro M L Flori
rdfs:label
Secukinumab shows high efficacy irrespective of HLA-Cw6 status in patients with moderate-to-severe plaque-type psoriasis: SUPREME study Secukinumab shows high efficacy irrespective of HLA-Cw6 status in patients with moderate-to-severe plaque-type psoriasis: SUPREME study
skos:prefLabel
Secukinumab shows high efficacy irrespective of HLA-Cw6 status in patients with moderate-to-severe plaque-type psoriasis: SUPREME study Secukinumab shows high efficacy irrespective of HLA-Cw6 status in patients with moderate-to-severe plaque-type psoriasis: SUPREME study
schema:name
Secukinumab shows high efficacy irrespective of HLA-Cw6 status in patients with moderate-to-severe plaque-type psoriasis: SUPREME study Secukinumab shows high efficacy irrespective of HLA-Cw6 status in patients with moderate-to-severe plaque-type psoriasis: SUPREME study
p:P50
wds:Q58434729-286E26DD-2C74-4320-BBD5-4A56BA1D25FE wds:Q58434729-70B64625-BE0D-40C3-A1AE-3CF1A35512A8 wds:Q58434729-110D7A87-28A6-41BE-A78A-094F507853FA
wdt:P50
wd:Q38319077 wd:Q86928474 wd:Q71192057
p:P1476
wds:Q58434729-E5724A32-0815-46F0-A888-66B6D60CFAD2
wdt:P1476
Secukinumab shows high efficacy irrespective of HLA-Cw6 status in patients with moderate-to-severe plaque-type psoriasis: SUPREME study
p:P304
wds:Q58434729-303D8843-6991-4C05-AD8F-159D0027F38D
wdt:P304
1072-1080
p:P31
wds:Q58434729-234B8E68-FC42-45BD-B0D5-9221930863FD
wdt:P31
wd:Q13442814
p:P921
wds:Q58434729-8516DE48-06AD-401E-91AA-ED5D790BEF0D
wdt:P921
wd:Q171171
p:P698
wds:Q58434729-17CCF94B-C8FC-4E0A-97CF-E4A866E9D658
wdtn:P698
n8:29704432
wdt:P698
29704432
p:P1433
wds:Q58434729-D9E5540A-0B28-4837-9945-14E126A12BF4
wdt:P1433
wd:Q4970191
p:P433
wds:Q58434729-4E9446DE-91DD-4737-A526-06738750DD23
p:P478
wds:Q58434729-5ED3B164-34D2-4BC6-965F-8A93F1D90AFA
wdt:P433
5
wdt:P478
179
p:P356
wds:Q58434729-9216B5CB-2A7B-487B-A0B0-52D7678C847C
wdtn:P356
n10:BJD.16705
wdt:P356
10.1111/BJD.16705